Gary Nachman analyst RAYMOND JAMES

Currently out of the existing stock ratings of Gary Nachman, 162 are a BUY (67.78%), 76 are a HOLD (31.8%), 1 are a SELL (0.42%).

Gary Nachman

Work Performance Price Targets & Ratings Chart

Analyst Gary Nachman works at RAYMOND JAMES with a stock forecast success ratio of 36.12% fulfilled within 109.79 days on average. Previously, Gary Nachman worked at BMO.

Gary Nachman’s has documented 494 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AQST, Aquestive Therapeutics at 28-Mar-2024.

Wall Street Analyst Gary Nachman

Analyst best performing recommendations are on LCI (LANNETT COMPANY).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 9/5/2019. The price target of $3 was fulfilled within 5 days with a profit of $1.41 (88.68%) receiving and performance score of 177.36.

Average potential price target upside

AMPH Amphastar P APTX Aptinyx AQST Aquestive Therapeutics BHC Bausch Health Companies ENDP Endo International PLC FLXN Flexion Therapeutics HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC LCI Lannett Company MNK Mallinckrodt plc MYL Viatris NEOS Neos Therapeutics OPTN OptiNose PCRX Pacira Pharmaceuticals SAGE Sage Therapeutic ABBV AbbVie PHAT Phathom Pharmaceuticals RIGL Rigel Pharmaceuticals PYPD PolyPid VTRS Viatris SRRK Scholar Rock Holding Corp TEVA Teva Pharma Industries Ltd ADR MORF Morphic ALNY Alnylam Pharmaceuticals ABCL Abcellera Biologics  EVLO Evelo Biosciences SDGR Schrodinger SLGL Sol Gel Technologies Ltd

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$27.52 (63.29%)


9 months 9 days ago

10/11 (90.91%)

$8.79 (14.13%)




$26.52 (60.99%)


9 months 23 days ago

2/3 (66.67%)

$8.35 (13.54%)




$0.52 (1.20%)


1 years 1 days ago

5/5 (100%)

$1.03 (2.40%)




$-25.16 (-43.26%)


2 years 2 months 8 days ago

3/3 (100%)

$-1.3 (-3.79%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Gary Nachman is most bullish on?

Potential upside of $22.58 has been obtained for ABBV (ABBVIE)

Which stock is Gary Nachman is most reserved on?

Potential downside of $3.89 has been obtained for AQST (AQUESTIVE THERAPEUTICS)

What Year was the first public recommendation made by Gary Nachman?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?